Clinical Trial Update: Acute Exacerbations Treated With BenRAlizumab (The ABRA Study) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on BenRAlizumab for acute exacerbations in asthma and COPD (the ABRA Study).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Benralizumab (benralizumab)

Snippet

Sponsor: University of Oxford | Conditions: Asthma, COPD | Phase 2 | Status: UNKNOWN